These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8091362)

  • 1. [Aminoglycoside determinations calculated in endocarditis vegetations. Relations with clinical practices during infectious endocarditis treatment with amikacin].
    Confesson MA; Barbaut X; Maire P; Vergnaud JM; el Brouzi A; Jelliffe RW
    Therapie; 1994; 49(1):27-34. PubMed ID: 8091362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computation of drug concentrations in endocardial vegetations in patients during antibiotic therapy.
    Maire P; Barbaut X; Vergnaud JM; el Brouzi M; Confesson MA; Pivot C; Chuzeville M; Ivanoff N; Brazier JL; Jelliffe RW
    Int J Biomed Comput; 1994 Jun; 36(1-2):77-85. PubMed ID: 7927862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravegetation antimicrobial distribution in aortic endocarditis analyzed by computer-generated model. Implications for treatment.
    Bayer AS; Crowell D; Nast CC; Norman DC; Borrelli RL
    Chest; 1990 Mar; 97(3):611-7. PubMed ID: 2106410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients.
    Mar Fernández de Gatta MD; Victoria Calvo M; Ardanuy R; Domínguez-Gil A; Lanao JM; Moreno SR
    J Pharm Pharmacol; 2009 Jun; 61(6):759-66. PubMed ID: 19505366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics and pharmacodynamics of amikacin and ceftazidime in tricuspid and aortic vegetations in experimental Pseudomonas endocarditis.
    Bayer AS; Crowell DJ; Yih J; Bradley DW; Norman DC
    J Infect Dis; 1988 Aug; 158(2):355-9. PubMed ID: 3042875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic aspects of therapy of experimental endocarditis.
    Carbon C; Crémieux AC; Fantin B
    Infect Dis Clin North Am; 1993 Mar; 7(1):37-51. PubMed ID: 8463652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibiotic therapy of infectious endocarditis (when, with what drug, how long?].
    Schuler G
    Z Kardiol; 1994 Jan; 83(1):2-8. PubMed ID: 8147065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo antibacterial effects of simulated human serum profiles of once-daily versus thrice-daily dosing of amikacin in a Serratia marcescens endocarditis experimental model.
    Bugnon D; Potel G; Xiong YQ; Caillon J; Kergueris MF; Le Conte P; Baron D; Drugeon H
    Antimicrob Agents Chemother; 1996 May; 40(5):1164-9. PubMed ID: 8723459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aminoglycosides in the treatment of infectious endocarditis].
    Malinverni R
    Schweiz Med Wochenschr Suppl; 1996; 76():14S-20S. PubMed ID: 8677414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case report of Cardiobacterium hominis endocarditis].
    Lesimple B; Dujardin JJ; Joly P; Hendricx S; Fievet P
    Ann Biol Clin (Paris); 2002; 60(4):468-70. PubMed ID: 12147451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of three dosage regimens of amikacin using pharmacokinetic models in patients with cystic fibrosis].
    Halacová M; Průsa R; Kotaska K; Vávrová V
    Cas Lek Cesk; 2004; 143(3):187-90. PubMed ID: 15134039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of antibiotics into vegetation of heart valves: a mathematical model.
    Eng RH; Parken P; Tecson-Tumang F
    Chemotherapy; 1982; 28(6):421-7. PubMed ID: 7160234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of amikacin dosing regimens in neutropenic guinea pigs with Escherichia coli infection.
    McClure JT; Rosin E
    Am J Vet Res; 1998 Jun; 59(6):750-5. PubMed ID: 9622746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibiotic treatment of infectious endocarditis].
    Sjursen H
    Tidsskr Nor Laegeforen; 2001 Nov; 121(28):3300-5. PubMed ID: 11826462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycoside resistant enterococcal endocarditis.
    Eliopoulos GM
    Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of amikacin in the subeschar tissue fluid following severe burns].
    Yang RH; Rong XZ; Zhang T; Hua R
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):172-4. PubMed ID: 17355928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
    Yang RH; Rong XZ; Hua R; Zhang T
    Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methods and monitoring of antibiotic therapy of infectious endocarditis].
    Besnier JM; Choutet P
    Rev Prat; 1998 Mar; 48(5):513-8. PubMed ID: 9781114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic analysis of amikacin and validation on neonates using Monte Carlo method.
    Wang J; Liang WQ; Wu JJ; Pan CM
    Acta Pharmacol Sin; 2000 Oct; 21(10):954-60. PubMed ID: 11501052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New formula for calculating antibiotic critical concentration by the disk diffusion method.
    Bednár M
    Med Sci Monit; 2000; 6(1):168-70. PubMed ID: 11208306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.